Skip to main content
Caplight Logo









Toro Neurovascular

Toro Neurovascular

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://www.toroneuro.com/

Last Round

Accelerator

Jun 5, 2025

Total Funding Raised

$3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Toro Neurovascular is a medical device company that develops advanced catheter technologies for the treatment of neurovascular diseases, including ischemic stroke.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurovascular catheterthrombectomyischemic strokeaspiration catheterstroke interventionneurointerventionclot retrievalmedical deviceminimally invasive surgeryinterventional neuroradiologyneurovascular accessstroke careendovascular deviceneuro-interventional tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Toro Neurovascular Comparables

Compare Toro Neurovascular with similar companies based on industry and business-model similarity.

Toro Neurovascular comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ceretrieve
87%
Penumbra
82%
Imperative Care
81%

Toro Neurovascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 5, 2025
SeedJul 25, 2024

Key People

Founding team and executive leadership

Ryan Walker

Co-Founder & COO

Founding Team

Hyung Posalit

Founder & CEO

Founding Team

Toro Neurovascular Investors

Notable investors and investment history

Toro Neurovascular investors
InvestorRounds
MedTech InnovatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 30, 2026

    Grew 27% QoQ from 11 to 14 employees.

  • May 6, 2026

    Grew 71% QoQ, from 7 to 12 employees.

Toro Neurovascular Filings

Explore SEC and related filing metadata, where available.

Toro Neurovascular filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Toro Neurovascular's valuation, stock price, and market status.

Is Toro Neurovascular a public or private company?

Toro Neurovascular is a private company.

What is the current stock price of Toro Neurovascular?

Toro Neurovascular is a private company with no public stock price. No recent secondary market data is available.

How much is Toro Neurovascular worth (valuation)?

Valuation information for Toro Neurovascular is not publicly available.

Can I buy Toro Neurovascular stock?

Toro Neurovascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Toro Neurovascular's last funding round?

Toro Neurovascular's most recent funding round was Accelerator on June 5, 2025.

Who are the main investors in Toro Neurovascular?

Key investors in Toro Neurovascular include MedTech Innovator.

Will Toro Neurovascular IPO soon?

No public IPO plans have been announced for Toro Neurovascular.

How can I track Toro Neurovascular secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Toro Neurovascular's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIrvine, California
Employee Range7
Year Founded2021
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?